BancFirst Trust & Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$742K Buy
603
+289
+92% +$295K 0.31% 25
2026
Q1
$278K Sell
314
-22
-7% -$22.3K 0.12% 34
2025
Q4
$363K Buy
336
+7
+2% +$6.69K 0.15% 28
2025
Q3
$239K Hold
329
0.09% 35
2025
Q2
$255K Sell
329
-73
-18% -$56.7K 0.12% 35
2025
Q1
$331K Sell
402
-30
-7% -$25K 0.16% 29
2024
Q4
$334K Hold
432
0.15% 40
2024
Q3
$379K Sell
432
-339
-44% -$305K 0.13% 38
2024
Q2
$701K Buy
771
+153
+25% +$122K 0.33% 21
2024
Q1
$481K Hold
618
0.23% 25
2023
Q4
$359K Hold
618
0.16% 32
2023
Q3
$336K Buy
618
+56
+10% +$28.9K 0.17% 28
2023
Q2
$261K Buy
+562
New +$236K 0.15% 36

Other funds holding LLY

BancFirst Trust & Investment Management's LLY Position: Q2 2026 in Review

BancFirst Trust & Investment Management increased its Eli Lilly (LLY) stake by 92% in Q2 2026, buying an estimated $295K and bringing the position to 603 shares worth $742K. The position accounts for 0.31% of the portfolio, ranked #25.

BancFirst Trust & Investment Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BancFirst Trust & Investment Management held 603 shares of Eli Lilly worth $742K as of Q2 2026.
  • BancFirst Trust & Investment Management bought 289 Eli Lilly shares in Q2 2026, an estimated $295K.
  • Eli Lilly made up 0.31% of BancFirst Trust & Investment Management's portfolio in Q2 2026, its #25 holding.
  • BancFirst Trust & Investment Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BancFirst Trust & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.